Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Lannett Co Inc (LCI) Common Stock USD0.001

Sell:$8.97 Buy:$8.98 Change: $0.22 (2.51%)
Market closed |  Prices as at close on 12 November 2019 | Switch to live prices |
Sell:$8.97
Buy:$8.98
Change: $0.22 (2.51%)
Market closed |  Prices as at close on 12 November 2019 | Switch to live prices |
Sell:$8.97
Buy:$8.98
Change: $0.22 (2.51%)
Market closed |  Prices as at close on 12 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.

Contact details

Address:
9000 State Rd
PHILADELPHIA
19136-1615
United States
Telephone:
+1 (215) 3339000
Website:
www.lannett.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LCI
ISIN:
US5160121019
Market cap:
$360.20 million
Shares in issue:
40.41 million
Sector:
Pharmaceuticals
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Patrick LePore
    Independent Chairman of the Board
  • Timothy Crew
    Chief Executive Officer, Director
  • John Kozlowski
    Chief Financial Officer, Vice President - Finance
  • John Abt
    Vice President and Chief Quality and Operations Officer
  • Maureen Cavanaugh
    Senior Vice President and Chief Commercial Operations Officer
  • Grant Brock
    Vice President - Operations
  • Robert Ehlinger
    Vice President - Logistics, Chief Information Officer
  • Samuel Israel
    General Counsel, Chief Legal Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.